Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma PatientsPaola Del Bianco(Istituto Oncologico Veneto), Susanna Mandruzzato(University of Padua)Frontiers in ImmunologyJanuary 7, 202210.3389/fimmu.2021.809826Cited by 21SaveCiteExport RISWatch citationsRelated PapersActivated T cells sustain myeloid-derived suppressor cell-mediated immune suppression|Oncotarget|2015|123